Global No.1
NTL is specializing in female cancer
with the world’s most advanced technology in the field of Cervicography,
A medical device for early diagnosis of uterine cervical cancer.
6,000,000
Cervicography Service
Ref) Internal Market Research
27
Business Experience
Ref) Internal Market Research
80
Market share in Korea
Ref) Internal Market Research
500000
Every year
Ref) Internal Market Research
Here we introduce
the main businesses of NTL
- CerviCARE AI enables to see get the results in a few seconds at the Point-of-Care.
- If an abnormality is found, it can be consulted by requesting reading to 45 professors specializing in gynecologic oncology at 32 university hospitals.
- NTL is specializing in female cancer with the world’s most advanced technology in the field of Cervicography,
A medical device for early diagnosis of uterine cervical cancer.
NOTICE
Title | Date | |
---|---|---|
NTL Showcases Advanced AI Medical Technology at KoINDEX in New Delhi, India
|
2024.12.05 | |
NTL Healthcare official website renewal
|
2023.05.31 | |
Release CerviCARE AI Service
|
2023.05.31 | |
TFDA Approval (Thailand Food and Drug Administration)
|
2023.05.31 |